Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique

International Journal of Pharmaceutics

Volumn 351, Issue 1-2, 2008, Pages 45-54

  Maghsoodi, Maryam ^a   Taghizadeh, Omid ^a   Martin, Gary P ^b   Nokhodchi, Ali ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

Author keywords

Crystallo co agglomeration; Direct tableting; Disintegrant; Disintegration time; Dissolution; Tensile strength

Indexed keywords

NAPROXEN;

AGGLOMERATION; ARTICLE; CHEMICAL PROCEDURES; CRYSTAL STRUCTURE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG STRUCTURE; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TABLET; X RAY DIFFRACTION;

ACETONE; CALORIMETRY, DIFFERENTIAL SCANNING; CELLULOSE; CRYSTALLIZATION; EXCIPIENTS; MICROSCOPY, ELECTRON, SCANNING; NAPROXEN; PARTICLE SIZE; SOLUBILITY; SOLVENTS; TABLETS; TECHNOLOGY, PHARMACEUTICAL; X-RAY DIFFRACTION;

EID: 38749088367     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.09.033     Document Type: Article

References (34)

1. Akbuga J. Preparation and evaluation of controlled release furosemide microsphere by spherical crsytallization. Int. J. Pharm. 53 (1989) 99-105
2. Carr R.L. Evaluation flow properties of solids. Chem. Eng. 72 (1965) 163-168
3. Carr R.L. Classifying flow properties of solids. Chem. Eng. 72 (1965) 69-72
4. Di Martino P., Barthelemy C., PPiva F., Joiris E., Palmieri G.E., and Martelli S. Improved dissolution behaviour of fenbufen by spherical crystallization. Drug Dev. Ind. Pharm. 25 (1999) 1073-1081
5. Fassihi A.R. Mechanisms of disintegration and compactibility of disintegrants in a direct compression system. Int. J. Pharm. 93 (1986) 32-36
6. Fell J.T., and Newton J.M. Determination of tablet strength by the diametral-compression test. J. Pharm. Sci. 59 (1970) 688-691
7. Gissinger D., and Stamm A. A comparative study of cross-linked carboxy methylcellulose as a tablet disintegrant. Pharm. Ind. 42 (1980) 189-192
8. Guillaume F., Guyothermann A.M., and Guyot J.C. Spherical crystallization of meprobamate. Farmaco 48 (1993) 473-485
9. Jbiilou M., Ettabia A., Gguyot-Hermann A.M., and Guyot J.C. Ibuprofen agglomerate preparation by phase separation. Drug Dev. Ind. Pharm. 25 (1999) 297-307
10. ® S100 spherical crystal agglomerates prepared by the solvent-change technique. Int. J. Pharm. 173 (1998) 61-74
11. Kadam, S.S., Mahadik, K.R., Paradkar, A.R., 1997a. A process for making agglomerates for use as or in a drug delivery system. Indian patent 183,036.
12. Kadam, S.S., Mahadik, K.R., Paradkar, A.R., 1997b. A process for making agglomerates for use as or in a drug delivery system. Indian patent 183,481.
13. Kawashima Y., Cui F., Takeuchi H., Niwa T., Hino T., and Kiuchi K.J. Parameters determining the agglomeration behaviour and the micromeritic properties of spherically agglomerated crystals prepared by the spherical crystallization technique with miscible solvent systems. Int. J. Pharm. 119 (1995) 139-147
14. Kawashima Y., Imai M., Takeuchi H., Yamamoto H., Kamiya K., and Hino T. Improved flowability and compactibility of spherically agglomerated crystals of ascorbic acid for direct tableting designed by spherical crystallization process. Powder Technol. 130 (2003) 283-289
15. Kawashima Y., Lin Y., Ogawa M., Handa T., and Takenaka H. Prolonged release microcapsules of indomethacin through spherical crystallization technique. J. Pharm. Sci. 74 (1985) 1152-1156
16. Khattab I., Menon A., and Sakr A. A study of the effect of disintegrant distribution ratio on the tablet characteristics using a central composite design. Eur. J. Pharm. Biopharm. 39 (1993) 260-263
17. Liberman H.A., Lachman L., and Schwartz J.B. Pharmaceutical Dosage Forms, Tablets vol. 2 (1989) pp. 173-177
18. Liversidge G.G. Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats. Int. J. Pharm. 125 (1995) 309-313
19. Liversidge G.G., and Cundy K.C. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs. I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int. J. Pharm. 125 (1995) 91-97
20. Maghsoodi, M., Hassanzadeh, D., Barzegar-Jallali, M., Martin, G., Nokhodchi, G., 2007. Improved compaction and packing properties of naproxen agglomerated crystals obtained by spherical crystallization technique. Drug Dev. Ind. Pharm., in press.
21. Merisko-Liversidge E., Liversidge G.G., and Cooper E.R. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur. J. Pharm. Sci. 18 (2003) 113-120
22. Merisko-Liversidge E., Sarpotdar P., Bruno J., Hajj S., Wei L., Peltier N., Rake J., Shaw J.M., Pugh S., Polin L., Jones J., Corbett T., Cooper E., and Liversidge G.G. Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs. Pharm. Res. 13 (1996) 272-278
23. Miller R.A., Down G.R.B., Yates C.H., and Millar J.F. An evaluation of selected tablet disintegrants-influence of disintegrants and compressional force on the dissolution of acetaminophen tablets. Can. J. Pharm. Sci. 15 (1980) 55-58
24. Mitchell S.A., Reynolds T.D., and Dasbach T.P. A compaction process to enhance dissolution of poorly water-soluble drugs using hydroxypropyl methylcellulose. Int. J. Pharm. 250 (2003) 3-11
25. Mura P., Faucci M.T., Manderioli A., Bramanti G., and Parrini P. Thermal behavior and dissolution properties of naproxen from binary and ternary solid dispersions. Drug Dev. Ind. Pharm. 25 (1999) 257-264
26. Mura P., Zerrouk N., Mennini N., Maestrelli F., and Chemtob C. Development and characterization of naproxen-chitosan solid systems with improved drug dissolution properties. Eur. J. Pharm. Sci. 19 (2003) 67-75
27. Nokhodchi A., Maghsoodi M., Hassanzadeh D., and Barzegar-Jalali M. Preparation of agglomerated crystals for improving flowability and compactibility of poorly flowable and compactible drugs and excipients. Powder Technol. 175 (2007) 73-81
28. Paradkar A.R., Pawar A.P., Mahadik K.R., and Kadam S.S. Spherical crystallization: a novel particle design technique. Indian Drugs 31 (1994) 229-233
29. Paradkar A.R., Pawal A.P., Chordiva A.P., Patil V.A., and Ketkar A.R. Spherical crystallization of celecoxib. Drug Dev. Ind. Pharm. 28 (2002) 1213-1220
30. Ribardiere A., Tchoreoff P., Couarraze G., and Puisieux F. Modification of ketoprofen bead structure produced by the spherical crystallization technique with a two-solvent system. Int. J. Pharm. 144 (1996) 195-207
31. Rubinstein M.H. The effect of disintegrants and processing on the bioavailability of furesemide from compressed tablets. Drug Dev. Ind. Pharm. 6 (1980) 105-119
32. Rundick A., Hunter A.R., and Holden F.C. An analysis of the diametral compression test. Mater. Res. Stand. 3 (1963) 283-289
33. Visavarungroj N., and Remon J.P. Cross linked starch as a disintegrating agent. Int. J. Pharm. 62 (1990) 125-131
34. Zhao N., and Augsburger L. The influence of granulation on super disintegrant performance. Pharm. Dev. Technol. 11 (2006) 47-53